Kotecha S - Search Results

1

Angiotensin II activates MAPK and stimulates growth of human pulmonary artery smooth muscle via AT1 receptors.

Morrell NW, Upton PD, Kotecha S, Huntley A, Yacoub MH, Polak JM, Wharton J. Morrell NW, et al. Among authors: kotecha s. Am J Physiol. 1999 Sep;277(3):L440-8. doi: 10.1152/ajplung.1999.277.3.L440. Am J Physiol. 1999. PMID: 10484450

2

Thalidomide reduces tumour necrosis factor-alpha production by human alveolar macrophages.

Tavares JL, Wangoo A, Dilworth P, Marshall B, Kotecha S, Shaw RJ. Tavares JL, et al. Among authors: kotecha s. Respir Med. 1997 Jan;91(1):31-9. doi: 10.1016/s0954-6111(97)90134-7. Respir Med. 1997. PMID: 9068814 Free article.

3

Pharmacological modulation of c-fos mRNA expression in the HL60 and U937 cell lines.

Kotecha S, Wilson L, Sutcliffe S, Wangoo A, Shaw RJ. Kotecha S, et al. Pulm Pharmacol. 1993 Dec;6(4):269-77. doi: 10.1006/pulp.1993.1036. Pulm Pharmacol. 1993. PMID: 7908546

4

Soluble L-selectin concentration in bronchoalveolar lavage fluid obtained from infants who develop chronic lung disease of prematurity.

Kotecha S, Silverman M, Shaw RJ, Klein N. Kotecha S, et al. Arch Dis Child Fetal Neonatal Ed. 1998 Mar;78(2):F143-7. doi: 10.1136/fn.78.2.f143. Arch Dis Child Fetal Neonatal Ed. 1998. PMID: 9577287 Free PMC article.

5

Dissimilarity of the gut-lung axis and dysbiosis of the lower airways in ventilated preterm infants.

Gallacher D, Mitchell E, Alber D, Wach R, Klein N, Marchesi JR, Kotecha S. Gallacher D, et al. Among authors: kotecha s. Eur Respir J. 2020 May 7;55(5):1901909. doi: 10.1183/13993003.01909-2019. Print 2020 May. Eur Respir J. 2020. PMID: 32060060 Free PMC article.

6

Prematurity-associated lung disease: looking beyond bronchopulmonary dysplasia.

Kotecha S, Doull I, Wild J, Bush A. Kotecha S, et al. Lancet Respir Med. 2022 May;10(5):e46. doi: 10.1016/S2213-2600(22)00098-4. Epub 2022 Mar 25. Lancet Respir Med. 2022. PMID: 35344740 Free article. No abstract available.

7

Epidermal growth factor in the lungs of infants developing chronic lung disease.

Currie AE, Vyas JR, MacDonald J, Field D, Kotecha S. Currie AE, et al. Among authors: kotecha s. Eur Respir J. 2001 Nov;18(5):796-800. doi: 10.1183/09031936.01.00088201. Eur Respir J. 2001. PMID: 11757630 Free article.

8

Pharmacological modulation of platelet-derived growth factor (B) mRNA expression in alveolar macrophages and adherent monocytes.

Kotecha S, Taylor IK, Shaw RJ. Kotecha S, et al. Pulm Pharmacol. 1994 Dec;7(6):383-91. doi: 10.1006/pulp.1994.1045. Pulm Pharmacol. 1994. PMID: 7549226

9

Platelet-derived growth factor-beta mRNA in human alveolar macrophages in vivo in asthma.

Taylor IK, Sorooshian M, Wangoo A, Haynes AR, Kotecha S, Mitchell DM, Shaw RJ. Taylor IK, et al. Among authors: kotecha s. Eur Respir J. 1994 Nov;7(11):1966-72. Eur Respir J. 1994. PMID: 7875266 Free article.

10

Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity.

Kotecha S, Wilson L, Wangoo A, Silverman M, Shaw RJ. Kotecha S, et al. Pediatr Res. 1996 Aug;40(2):250-6. doi: 10.1203/00006450-199608000-00010. Pediatr Res. 1996. PMID: 8827773

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters